ELIXIRGEN THERAPEUTICS, INC.

New Filing
CIK: 0001744333·Biotechnology·DELAWARE·Filed: Apr 9, 2025
Total Offering

$3,600,000

Amount Sold

$3,600,000

Investors

2

First Sale

Mar 31, 2025

Offering Details

Type
Debt, Option to Acquire, Security to be Acquired
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
AKIHIRO KO
Related Person
HIROAKI KOBAYASHI
Related Person
MINORU KO
Related Person
THOMAS WHITE
Related Person
SHAUNA CALLAHAN
Related Person
JEFFREY CLELAND
Related Person

Company

ELIXIRGEN THERAPEUTICS, INC.

855 N. WOLFE ST.

BALTIMORE, MD, 21205

443-451-5300

SEC Filing

0001744333-25-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
ELIXIRGEN THERAPEUTICS, INC. Form D Filing — $3,600,000 | FilingFlow